-
1
المؤلفون: Whichello, Chiara, van Overbeeke, Eline, Janssens, Rosanne, Schölin Bywall, Karin, Russo, Selena, Weldwijk, Jorien, Cleemput, Irina, Juhaeri, Juhaeri, Levitan, Bennet, Kübler, Jürgen, Smith, Meredith, Hermann, Richard, Engelbrecht, Matthias, Heuber, Alex J., Comanescu, Alina, Harding, Sarah, Simoens, Steven, Huys, Isabelle, de Bekker-Grob, Esther
المصدر: IMI-PREFER Frontiers in Pharmacology. 10
مصطلحات موضوعية: patient preferences, drug life cycle, decision-making, health technology assessment, benefit risk assessment, market authorization
وصف الملف: print
URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-62348
https://doi.org/10.3389/fphar.2019.01009 -
2
المؤلفون: Whichello, Chiara, van Overbeeke, Eline, Janssens, Rosanne, Schölin Bywall, Karin, Russo, Selena, Weldwijk, Jorien, Cleemput, Irina, Juhaeri, Juhaeri, Levitan, Bennet, Kübler, Jürgen, Smith, Meredith, Hermann, Richard, Engelbrecht, Matthias, Heuber, Alex J., Comanescu, Alina, Harding, Sarah, Simoens, Steven, Huys, Isabelle, de Bekker-Grob, Esther
المصدر: IMI-PREFER Frontiers in Pharmacology. 10
مصطلحات موضوعية: patient preferences, drug life cycle, decision-making, health technology assessment, benefit risk assessment, market authorization
وصف الملف: electronic
URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393365
https://doi.org/10.3389/fphar.2019.01009
https://uu.diva-portal.org/smash/get/diva2:1352851/FULLTEXT01.pdf